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Abstract
An epitope-specific polyclonal antiserum was produced in rabbits immunized against a
synthetic 15 amino acid peptide (QRVTGLDFIPGLHPV) derived from the coding sequence
reported for the porcine leptin gene (GenBank Accession No. U59894). This peptide contains a
core sequence comprised of eight amino acids (GLDFIPGL) that is totally conserved in all
leptin proteins studied to date. Purified recombinant human, mouse, rat, pig, and chicken leptin
proteins were separated by polyacrylamide gel electrophoresis (SDS-PAGE) and electro-blotted
onto PVDF membranes. Western blots were developed employing the leptin-specific peptide
antiserum with an alkaline-phosphatase-conjugated anti-rabbit IgG second antibody
chromogenic system. The peptide antiserum was found to be highly specific for leptin which
exhibited an estimated molecular weight of about 16 kDa for all species analyzed. The
sensitivity of the Western blot assay was not sufficient to permit the direct detection of leptin
in chicken serum or plasma. However, with this assay we were able to detect native leptin
protein in an enriched fraction prepared from chicken plasma using a combination of gel
filtration and ion exchange column chromatography. Slot blots indicated a potential application
of the immunostaining technique for quantitative analysis of leptin protein. Finally, the peptide
antiserum was successfully employed to localize leptin protein by immunohistochemical stain-
ing of thin sections prepared from adipose (chicken and pig) and liver (chicken) tissue
samples. This study is the first to report a polyclonal peptide antiserum that apparently
recognizes intact leptin protein, both native and recombinant, regardless of the species of
origin. Ó 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Leptin, a polypeptide hormone involved in the regulation of food intake, energy
balance and body weight, is encoded by the obese gene (ob) that has recently been
identified and characterized in a number of animal species as well as in humans [1].
After intracellular processing of the 167 amino acid pro-hormone to cleave a 21 amino
acid signal peptide segment, the mature form of leptin is secreted into the bloodstream
where it circulates as a 146 amino acid (16 kDa) protein [1]. Crystal structure and NMR
studies have characterized leptin as a four-helix bundle cytokine containing a single
disulfide bond (Cys –Cys ) that is essential, both to its structure and to its function96 146
[2,3]. In mammals, leptin is expressed primarily in white adipose tissue, although other
tissues such as gastric epithelial lining, placenta, muscle, brain, pituitary, and hypo-
thalamus have also been found to be sites of leptin expression [1]. In chickens, leptin is
produced by liver and adipose tissue, with liver being the predominant site of expression
[4,5]. Leptin has been reported to function in the regulation of appetite, energy
metabolism, fertility, and in the maintenance of body weight by acting as a peripheral
hormone ‘sensor’ for the size of adipocyte energy (lipid) stores [6].
Receptors, similar to those of the class I cytokine receptor super-family, have been
identified for leptin in the central nervous system as well as in peripheral tissue locations
[7]. In the hypothalamus, leptin has been reported to suppress neuronal levels of
neuropeptide Y (NPY) and agouti-related peptide (AGRP), while stimulating the
production of proopiomelanocortin (POMC) [8]. Together, these actions and other less
well characterized neuroendocrine signaling pathways bring about a suppression of
feeding behavior as well as changes in energy expenditure and body weight. Although
leptin genes have been identified in sheep, cattle, pigs and chickens, relatively little is
known about its specific role(s) in regulating appetite, energy metabolism, and body
weight in farm animals [9,10].
Methodologies for the assay of leptin protein in serum or plasma (i.e., radioim-
munoassay, RIA, and enzyme-linked immunoassay, ELISA) have been developed
primarily for the determination of rodent or human leptin proteins. However, the antisera
and antibodies employed in these assays exhibit varying degrees of species-specificity
that constrains their application to accurately measure leptin protein in samples obtained
from a broader range of animal species. The objective of this work was to develop an
antiserum that would be useful in the immunological detection of leptin protein without
regard to its species of origin. To do this we compared the published amino acid
sequences derived from the coding sequences for all reported leptin genes and
determined unique regions of conservation (Fig. 1). We chose a specific sequence in the
AB loop region of porcine leptin and synthesized a 15 amino acid peptide against which
a polyclonal antiserum was produced by immunizing rabbits with a KLH-conjugated
peptide antigen. Our results, reported here, detail the use of this polyclonal peptide
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Fig. 1. Amino acid sequence comparison for pig (P), chicken (C), human (H), rat (R), mouse (M), bovine
(B), sheep (S) and dog (D) leptin proteins (mature form without the signal peptide sequence). Amino acid
sequences were derived from gene coding sequence data deposited in GenBank or from a previous report [2].
Shaded boxes indicate contiguous, totally conserved regions of amino acid sequence within the protein. The
unshaded box in the pig (P) leptin sequence (amino acids 34–48) defines the position of the 15 amino acid
peptide that was used to generate the peptide antiserum for this study. Also indicated are the a-helical (A–E)
and interconnecting (loop) regions in the leptin protein structure.
antiserum in the detection of recombinant and/or native leptin protein from different
animal species.
2. Materials and methods
2.1. Materials
Recombinant human and mouse leptin were purchased from CalBiochem (La Jolla,
CA, USA), recombinant rat leptin was purchased from R&D Systems (Minneapolis,
MN, USA), recombinant chicken leptin was provided by Dr. A.F. Parlow (National
Hormone and Pituitary Program, Torrance, CA, USA), recombinant porcine leptin was
supplied by Dr. Tim Ramsay (USDA, Growth Biology Laboratory, Beltsville, MD,
USA) and a recombinant bovine leptin /glutathione-S-transferase fusion protein was
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kindly provided by Dr. Roger Stone (USDA, ARS, Clay Center, NB, USA). All purified
recombinant leptin proteins were reconstituted in phosphate buffered saline (PBS) at pH
7.4. Chicken plasma was obtained by cardiac puncture of 8-week-old male broiler-
breeder birds. Tissue samples of liver, subcutaneous fat, and abdominal fat were
obtained from 5-month-old, cross-bred (Poland China 3 Landrace) gilts weighing
approximately 80 kg and from 4-week-old male broiler-breeder chickens weighing
approximately 1.1 kg. All studies involving the use of animals were conducted in
accordance with research protocols approved by the Beltsville Animal Care and Use
Committee.
2.2. Peptide synthesis and antiserum production
Peptide synthesis and antiserum production were conducted according to standard and
proprietary protocols (GenoSys Biotechnologies Inc., The Woodlands, TX, USA).
Briefly, a peptide corresponding to a portion of the porcine leptin protein sequence
( QRVTGLDFIPGLHPV ) was synthesized using a solid phase support and FMOC34 48
chemistry. Two milligrams of this peptide was conjugated to 150 mg of keyhole limpet
hemocyanin (KLH) using a water soluble carbodiimide. The KLH–peptide conjugate
was purified by gel filtration chromatography and freeze dried. After reconstitution in
deionized water, the conjugate was mixed with either complete or incomplete Freund’s
adjuvant just prior to immunization of two New Zealand white rabbits. Twelve separate
injections of the peptide–KLH conjugate were made for each rabbit at 2-week intervals.
Each injection was divided among multiple subcutaneous sites and delivered a total of
0.1 mg of peptide. The initial immunization was given in complete Freund’s adjuvant
and all subsequent (booster) immunizations were given in incomplete Freund’s adjuvant.
Blood (yielding 25–30 ml of serum per rabbit) was collected prior to immunization and
at 2-week intervals commencing on the seventh week following the initial immunization.
Serum antibody titer (determined by ELISA using the peptide antigen) rapidly rose to
1:50,000 and held constant at that level throughout the remaining immunization period.
2.3. Column chromatography
Neat chicken plasma (350 ml) was divided into 50 ml aliquots and fractionated on a
column (5.0 3 70 cm) packed with Sephacryl S-300 HR (Amersham Pharmacia Biotech,
Piscataway, NJ, USA) and equilibrated with PBS at pH 7.4. Pooled leptin-containing
fractions were concentrated by ultrafiltration (YM3 membrane, Amicon Inc., Beverly,
MA, USA) and applied to a second column (2.5 3 90 cm) packed with Sephadex G-50
and equilibrated with PBS at pH 7.4. Fractions comprising the second of the three peaks
eluting from the G-50 column were pooled, concentrated by ultrafiltration, diluted
(1:100 in 25 mM Tris–HCl, pH 8.0), and applied to a third column (5.0 3 5.0 cm)
packed with DEAE-Sephacel (Amersham Pharmacia Biotech) equilibrated with 25 mM
Tris–HCl, pH 8.0. Proteins were eluted with a linear 500 ml gradient of 0–250 mM
NaCl in 25 mM Tris–HCl, pH 8.0. Pooled fractions containing leptin were concentrated
and desalted by repeated ultrafiltration against deionized water prior to Western blot
analysis (see below). Potential leptin-containing fractions from chicken plasma were
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identified at each step of the chromatographic procedure by determining the elution
characteristics of a human recombinant leptin standard subjected to identical chromato-
graphic conditions.
2.4. Western blot analysis
Recombinant leptin proteins (200 ng per lane) and the leptin-enriched fraction
prepared from chicken plasma were subjected to SDS-PAGE using 13% polyacrylamide
separating gels under reducing conditions according to the method of Laemmli [11].
Separated proteins were transferred from the gels to PVDF membranes (Immobilon-P,
Millipore Corp., Bedford, MA, USA) using a semi-dry electro-blotting system (Bio-Rad
Laboratories, Hercules, CA, USA) for 1 h at 16–24 V in a Tris–glycine buffer
containing 20% methanol. The blots were stained for total protein with Coomassie blue
prior to blocking with BSA (Cat. [A7888, Sigma, St. Louis, MO, USA). The blots were
then incubated with diluted peptide-antiserum (1:6000) followed by an alkaline
phosphatase-conjugated second antibody directed against rabbit IgG (Sigma). Immuno-
reactive bands were visualized with a color generating system comprised of an alkaline
phosphatase substrate, 5-bromo-4-chloro-3-indoyl phosphate and nitro blue tetrazolium
(BCIP/NBT). Tris–saline buffers containing 0.05% Tween-20, 0.5% BSA, and 0.5%
gelatin were used for dilutions and all incubations with antiserum and the second
antibody.
2.5. Slot blot analysis
Recombinant human leptin protein samples were transferred to 0.2 mm nitrocellulose
membranes using a slot blotting device under light vacuum (Bio-Rad). Leptin protein
adsorbed to the membrane was visualized using the immunostaining technique described
previously for Western blot analysis with a 1:5000 dilution of the peptide antiserum.
Each blot containing varying amounts of human recombinant leptin (10–600 ng per slot)
was replicated in six different assays with two to four individual determinations per slot.
Blanks containing either no added protein or 1.5 mg of BSA served to assess the level of
background staining. The blots were scanned and the resulting stained bands quantified
using a laser densitometer (Molecular Dynamics, Sunnyvale, CA, USA). Slot volume
(band intensity) was plotted against the amount of leptin added to each slot and linear
regression analysis was used to fit a line to the combined data points.
2.6. Immunohistochemistry
Samples of adipose and liver tissue obtained from chickens and pigs were fixed
overnight in Bouin’s solution, embedded in paraffin, sectioned at 6 mm, and the sections
mounted on poly-L-lysine coated glass slides. Following deparaffinizing in xylene, tissue
sections were rehydrated by passing them through decreasing concentrations of ethyl
alcohol to Tris-buffered saline. Endogenous peroxidase activity was eliminated by
incubating the sections for 30 min in methanolic H O . Nonspecific binding was2 2
blocked with normal goat serum followed by an overnight incubation with anti-leptin
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peptide-antiserum (1:2000 dilution). Immunoreactive leptin protein was visualized with
an avidin–biotin-enhanced horseradish peroxidase method (Vector Laboratories, Burl-
ingame, CA, USA) using diaminobenzadine as the substrate, followed by a light nuclear
counter-stain with Gill’s hematoxylin.
3. Results and discussion
A high-titer, polyclonal peptide antiserum was produced in rabbits that recognizes an
epitope containing a specific eight amino acid core sequence (GLDFIPGL) found in the
AB loop portion of all known leptin proteins. Although raised against a KLH-conjugated
peptide antigen, this antiserum recognizes intact recombinant leptin proteins in a Western
blot assay system for a number of different species tested to date including: human,
mouse, rat, pig and chicken (Fig. 2, lanes 2–6). Fractionation of plasma using a
combination of gel filtration (Sephacryl S-300 and Sephadex G-50) and anion exchange
(DEAE-Sephacel) column chromatography followed by concentration of the sample by
ultrafiltration, allowed us to detect native chicken leptin (Fig. 2, lane 1). Recombinant
bovine leptin (produced as a glutathione-S-transferase fusion protein) was also detected
using the Western blotting procedure (data not shown).
To evaluate the quantitative nature of immunostaining, different amounts of recombi-
nant human leptin were vacuum blotted onto nitrocellulose membranes using a slot
Fig. 2. Western blot analysis of chicken (lane 2), human (lane 3), mouse (lane 4) rat (lane 5), and pig (lane 6)
purified recombinant leptin proteins (200 ng per lane). Lane 1 shows an enriched leptin-containing extract from
chicken plasma that had been subjected to prior gel-filtration followed by anion exchange chromatographic
fractionation.
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blotting device and the bands were developed with the double antibody staining system
used for Western blot analysis. With this approach, a standard curve was constructed
using 10 to 600 ng of human recombinant leptin (Fig. 3). Band intensity (i.e., slot
volume), quantified by scanning laser densitometry, showed a significant linear response
2(r 5 0.914) between 20 and 500 ng of added leptin protein. These preliminary findings
suggest that the peptide antiserum in conjunction with slot blotting may be a useful tool
for monitoring the level of leptin protein during purification of recombinant or native
proteins. However, sample matrix effects, which can affect the binding of protein to the
membranes, may limit the usefulness of this technique to estimating the quantity of
leptin in purified or highly enriched samples. Further evaluation is required to determine
the utility of this method for the quantification of leptin protein.
Initial determinations of the specific localization of leptin protein were obtained and
verified from serial cut sections of paraffin embedded adipose and liver tissue samples
incubated with anti-leptin antiserum pre-adsorbed and immuno-neutralized with either
the immunization peptide (10 mg/ml) or recombinant human leptin (1 mg/ml). In the
pig, the absence of positive immunostaining for leptin in tissues other than those
containing adipocytes demonstrated an absence of random, nonspecific binding of the
antibody to cell structures not containing leptin. Pre-adsorption of the antibody resulted
Fig. 3. Slot blot analysis of purified human recombinant leptin. A composite standard curve was constructed
from the results of six separate blots with varying amounts (10–600 ng) of added protein per slot. The curve
2demonstrates a significant linear response (r 5 0.914) between 20 and 500 ng of added leptin protein with a
lower limit of detection estimated at about 10–20 ng. Each value represents the mean6S.E.M. of two to four
individual determinations and the plotted line was derived from standard linear regression analysis of the
combined data.
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in a significant reduction or elimination of immunostaining for leptin (data not shown).
Liver, ileum, and muscle from the same pig presented no indication of positive
immunostaining for leptin with this antiserum (data not shown). In the sub-dermal
regions of skin, some evidence of positive staining for leptin was evident, presumably at
the junction with cells differentiating into adipocytes. Immunostaining for leptin was
prominent in most adipocytes (omental and back fat tissue), in particular in interior
membrane areas where two or more cells were adjacent and the nucleus was present
(Fig. 4a,b). In abdominal adipose tissue (fat pad) obtained from a 4-week-old male
broiler chicken, positive staining for leptin was observed in both nuclear and plasma
membrane-associated regions (Fig. 4c). Unlike in the pig, leptin staining was detected in
chicken liver tissue (Fig. 4d). While relative leptin expression in chickens has been
shown to be higher in liver than adipose tissue [4,5], immunohistochemical staining of
leptin in hepatic cytoplasm was diffuse and light as compared to adipocytes (compare
Fig. 4c,d). Perhaps this reflects differences in the intracellular transit time of leptin (a
secreted protein) between these two tissues. In the chicken, positive staining for leptin
was apparent in nuclear as well as plasma membrane-associated regions in both
adipocytes and hepatocytes (Fig. 4c,d).
Fig. 4. Immunohistochemical localization of leptin protein in thin sections prepared from omental fat (a) and
backfat (b) obtained from 80 kg cross-bred gilts and abdominal fat pad (c) and liver (d) collected from a
4-week-old broiler chicken.
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Table 1
Evaluation of a peptide antiserum for cross-species leptin protein analyses
Application Evaluation Recommendations
Western blot Useful Dilutions up to 1:8000; lower limit
of detection in the low ng range
Slot blot Useful Dilution at 1:5000; lower limit of
detection in the 10–20 ng range,
but sample matrix effects may limit
application
Immunohistochemistry Useful Dilution at 1:2000; use double
antibody detection method
Enzyme-linked Possible Use as a universal capture antibody to
immunoassay coat plates or as a universal detection
antibody for ELISA
Affinity purification Possible For native leptin purification
4. Simplified method description and future applications
A high-titer polyclonal peptide-antiserum that recognizes intact leptin protein was
produced in rabbits immunized against a KLH-conjugated synthetic peptide containing a
totally conserved eight amino acid core sequence. This antiserum was employed in both
Western and slot blot analyses to detect and quantify leptin protein, as well as in
immunohistochemical staining of prepared thin sections from adipose and liver tissue
samples. The ‘universal’ species recognition characteristics of this antiserum make it a
potentially useful reagent for leptin immunoassay development covering a wide range of
animal species, including humans, without the constraints of variable cross-reactivity
that characterizes other available leptin antisera and purified antibodies. Some of the
applications for this peptide antiserum are summarized in Table 1. The latter two
potential uses (enzyme-linked immunoassay and affinity purification) would require
further enrichment of the leptin-specific antibodies by production of an IgG-enriched
fraction and/or affinity purification of the antibodies using the peptide antigen. Both of
these enrichments can be readily achieved using established antibody purification
techniques. A preliminary evaluation of this antiserum suggests that it may not be
suitable for development of a leptin-specific radioimmunoassay. This could reflect an
inability of the antibodies to form a precipitating complex with leptin protein due to the
limited size of the epitope recognized. In support of this idea, the peptide antiserum was
also found to be ineffective in a standard radial diffusion immunoassay (data not shown)
which requires the precipitation of an antibody–antigen complex.
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